• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mymd Pharmaceuticals Inc (NQ: MYMD )

    1.820 UNCHANGED
    Last Price Updated: 3:38 PM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Mymd Pharmaceuticals Inc

    < Previous 1 2 3 4 5 6 Next >
    12 Health Care Stocks Moving In Monday's After-Market Session
      
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
      
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Good morning! We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday! 
    Via InvestorPlace
    Why Is Toast Trading Higher By 20%: Here Are 34 Stocks Moving Premarket
    Gainers Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 66.9% to $2.37 in pre-market trading. Neptune Wellness Solutions recently announced voluntary delisting from Toronto Stock Exchange. 
    Via Benzinga
    Data Showing MyMD Pharmaceuticals’ MYMD-1® May Extend Life and Improve Health Published in the Journal of Gerontology: Biological Sciences
    From MyMD Pharmaceuticals, Inc.
    Via Business Wire
    Recap Of Tuesday's Biotech Catalysts - End of The Day Summary
    Via Benzinga
    MyMD Pharmaceuticals® Advances Phase 2 Multi-Center Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan
    From MyMD Pharmaceuticals, Inc.
    Via Business Wire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Good morning! We're starting the last day of trading this week with a breakdown of the biggest pre-market stock movers for Friday! 
    Via InvestorPlace
    Why Is Pinterest Higher By 14%? 20 Stocks Moving In Friday's Pre-Market Session
    Gainers United Maritime Corporation (NASDAQ: USEA) rose 55% to $3.41 in pre-market trading. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Gainers Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion. 
    Via Benzinga
    Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday
    Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th. 
    Via Benzinga
    MyMD Pharmaceuticals to Collaborate with Bascom Palmer Eye Institute to Study MYMD-1 in Ophthalmic Conditions
    From MyMD Pharmaceuticals, Inc.
    Via Business Wire
    Boeing, PriceSmart And 80 Biggest Movers From Yesterday
    Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share. 
    Via Benzinga
    Tesla, Twitter And 76 Biggest Movers From Friday
    Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
      
    Via Benzinga
    Dow Turns Positive After Better-Than-Expected Jobs Report
    U.S. stocks turned higher midway through as investors digested the recent jobs report for the month of June. 
    Via Benzinga
    Tesla, WD-40 Company And 40 Stocks Moving In Friday's Mid-Day Session
    Gainers Aditxt, Inc. (NASDAQ: ADTX) shares surged 75.7% to $0.2812 after the company's Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100. 
    Via Benzinga
    Why U.S. Stocks Are Trading Lower Despite Upbeat Nonfarm Payrolls Report
    U.S. stocks traded lower this morning following the release of jobs report for the month of June. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Twitter And 20 Stocks Moving Premarket
    Gainers Seritage Growth Properties (NYSE: SRG) rose 35.7% to $8.25 in pre-market trading after gaining around 10% on Thursday. Seritage Growth Properties filed its preliminary proxy materials with the... 
    Via Benzinga
    Recap of Tuesday's Biotech Catalysts - End of the Day Summary
    Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid... 
    Via Benzinga
    MyMD Pharmaceuticals Advances Phase 2 Multi-Center Clinical Trial of MYMD-1 as a Therapy for Delaying Aging and Extending Healthy Lifespan
    From MyMD Pharmaceuticals, Inc.
    Via Business Wire
    MyMD Pharmaceuticals Accelerates Pace of New Patient Dosing in Phase 2 Clinical Trial of MYMD-1 as a Therapy for Delaying Aging and Extending Healthy Lifespan
    From MyMD Pharmaceuticals, Inc.
    Via Business Wire
    MyMD Pharmaceuticals Announces Live Appearance on Cheddar News Network Today March 24
    From MyMD Pharmaceuticals, Inc.
    Via Business Wire
    99 Biggest Movers From Yesterday
    Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Gainers Sonnet BioTherapeutics (NASDAQ:SONN) stock rose 85.6% to $0.51 during Wednesday's pre-market session. The company's market cap stands at $30.8 million.... 
    Via Benzinga
    MyMD Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial of MYMD-1 as a Therapy for Delaying Aging and Extending Healthy Lifespan
    From MyMD Pharmaceuticals, Inc.
    Via Business Wire
    Not Science Fiction Anymore? MyMD Moves Into Phase 2 Research For A Pill To Reportedly Slow Down Aging
    Image provided by Pexels This post contains sponsored advertising content paid for by MyMD. This content is for informational purposes only and is not intended to be investing... 
    Via Benzinga
    MyMD Pharmaceuticals Announces Positive Clinical Data in Advance of Upcoming Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
    From MyMD Pharmaceuticals, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock increased by 28.7% to $2.24 during Thursday's pre-market session. The company's market cap stands at $31.4... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.